Saphris approved for schizophrenia and bipolar I disorder - MPR
Links shared publicly online about this topic.
- 1,824total visits
Saphris approved for schizophrenia and bipolar I disorder - MPR
empr.com —
View full resource at empr.com
Tags: Schizophrenia, Psychotic Disorder, Disease and Condition, FDA, News
Most Recently Shared on August 14, 2009 at 4:08 pm By:
MPR News: Saphris approved for schizophrenia and bipolar I disorder: The FDA has approved Saphris (asen.. http://bit.ly/A4RkP
Cariprazine Hits Mark in Phase 3 Study
dddmag.com — “Forest Laboratories Inc. said its experimental bipolar disorder drug, cariprazine, met its goal in a late-stage clinical study. Forest plans to ask the FDA to approve capirizane as a treatment for acute bipolar mania and schizophrenia in 2012.” View full resource at dddmag.com
Most Recently Shared on October 7, 2011 at 5:54 am By:
Cariprazine Hits Mark in Phase 3 Study - Drug Discovery & Development http://t.co/gmI8njj0
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Lithium or Valproate
drugs.com — “Abilify (aripiprazole) is used to treat schizophrenia, Bipolar I Disorder, depression and irritability associated with autistic disorder. Includes Abilify side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 21, 2011 at 10:15 pm By:
Drugs and Devices OW OW Health
Abilify (aripiprazole) Approved for Maintenance Treatment of Bipolar I Disorder as an Adjunct to Either Li... http://bit.ly/fuFJIk #drug
Saphris gains indications - ONA
oncologynurseadvisor.com — “Merck announced that Saphris (asenapine sublingual tablets) has been approved for two additional indications: 1) the maintenance treatment of schizophrenia and 2) as adjunctive therapy with either lithium or valproate for the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.” View full resource at oncologynurseadvisor.com
Most Recently Shared on January 25, 2011 at 7:47 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Saphris gains indications http://goo.gl/fb/fG2TE
FDA Okays New Antipsychotic for Schizophrenia, Bipolar Disorder | Discuss Pharmacy
discusspharmacy.com — “WASHINGTON -- The FDA approved the atypical antipsychotic asenapine (Saphris) for schizophrenia and bipolar disorder in adults, making it the first” View full resource at discusspharmacy.com
Most Recently Shared on December 9, 2010 at 1:23 pm By:
Peter H Brown Doctor and Psychologist
FDA Okays New Antipsychotic for Schizophrenia, Bipolar Disorder ... http://bit.ly/ifxZ4S #bipolar
Psychiatry Article | Olanzapine
mdlinx.com — “Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients” View full resource at mdlinx.com
Most Recently Shared on December 2, 2010 at 8:50 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipola... http://bit.ly/h2uM2i #PSY
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asenapine) Sublingual Tablets
drugs.com — “Saphris (asenapine) is used for the treatment of schizophrenia and bipolar I disorder. Saphris information includes news, clinical trial results and side effects.” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 1:14 am By:
Drugs and Devices OW OW Health
Merck Receives Approval from FDA for Expanded Indications for Atypical Antipsychotic Medication Saphris (asen... http://bit.ly/cBfzbG #drug
Treatment With SAPHRIS® (asenapine) Sublingual Tablets
saphris.com — “SAPHRIS medication is commonly used to treat bipolar I disorder and schizophrenia in adults. Visit SAPHRIS and learn more about common symptoms and treatment.” View full resource at saphris.com
Most Recently Shared on July 15, 2010 at 5:44 pm By:
HealthEd Health Business and Medical Education
We're pleased and proud to announce the launch of http://www.saphris.com
Asenapine for schizophrenia and bipolar I disorder — Current Psychiatry Online
currentpsychiatry.com — “Asenapine for schizophrenia and bipolar I disorder — Current Psychiatry Online” View full resource at currentpsychiatry.com
Most Recently Shared on December 18, 2009 at 3:17 pm By:
Current Psychiatry Psychiatry and Medical Journal
Asenapine (Saphris)--new med for schizophrenia & bipolar I--offers unique receptor profile, sublingual delivery http://bit.ly/5BO6G2
FDA Approves Lilly's Zyprexa for Two Adolescent Indications
drugs.com — “Zyprexa (olanzapine) is used to treat Schizophrenia and Bipolar I Disorder in Adolescents. Includes Zyprexa side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on December 7, 2009 at 11:54 pm By:
FDA Approves Lilly's Zyprexa for Two Adolescent Indications - http://bit.ly/7VAdnv
Saphris: It's Different without Actually Being Different | Psydir News
news.psydir.com — “On August 14th, the FDA approved Schering-Plough's second generation antipsychotic drug Saphris (asenapine) for the acute treatment of schizophrenia, and the acute treatment of mania/mixed episodes associated with bipolar I disorder (1). Question: Should I, at all be concerned that there are more actual published peer-reviewed articles of this drug being tested in rats (2, 3, 4, 5, 6 ) than in hum...” View full resource at news.psydir.com
Most Recently Shared on September 4, 2009 at 11:34 am By:
Saphris: It's Different without Actually Being Different http://ow.ly/15NICd
FDA OKs Schering-Plough Drug for Schizophrenia, Bipolar - WSJ.com
online.wsj.com — “The FDA gave final approval to Schering-Plough's Saphris, a treatment for both schizophrenia and bipolar disorder in adults.” View full resource at online.wsj.com
Most Recently Shared on August 19, 2009 at 7:15 pm By:
The Medpedia Project Health Site
FDA Approves Asenapine for Schizophrenia, Bipolar Disorder: http://bit.ly/4uyHBi
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder
medicalnewstoday.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder i” View full resource at medicalnewstoday.com
Most Recently Shared on August 16, 2009 at 12:35 pm By:
psychiatryrounds Psychiatry and Support
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder: The U.S. Food and Drug Adm.. http://bit.ly/ePdzL
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder | Psydir News
news.psydir.com — “The U.S. Food and Drug Administration has approved Saphris tablets (asenapine) to treat adults with schizophrenia, a chronic, severe and disabling brain disorder, and to treat bipolar I disorder in adults, a serious psychiatric disorder that causes shifts in a person's mood, energy, and ability to function.” View full resource at news.psydir.com
Most Recently Shared on August 16, 2009 at 12:31 pm By:
FDA Approves Saphris Tablets (asenapine) To Treat Schizophrenia And Bipolar Disorder http://ow.ly/15Ldfh
Schering-Plough Announces FDA Approval of Saphris (asenapine)
drugs.com — “Saphris (asenapine) is used to treat schizophrenia and bipolar I disorder. Includes Saphris side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 15, 2009 at 6:07 am By:
Schering-Plough Announces FDA Approval of Saphris (asenapine) - http://bit.ly/XvAmd
Saphris Approved for Schizophrenia and Bipolar Disorder
halifaxhealth.org — “Saphris Approved for Schizophrenia and Bipolar Disorder” View full resource at halifaxhealth.org
Most Recently Shared on August 14, 2009 at 7:37 pm By:
Halifax Health Healthcare System
Saphris Approved for Schizophrenia and Bipolar Disorder http://bit.ly/XBhtu
Advertisement
